North Carolina Hemp Crackdown: Senate Votes, Industry Impact & Legal Changes

Executive Summary

North Carolina's Senate voted in July 2026 to impose sweeping restrictions on hemp-derived intoxicating cannabinoids, marking the state's most aggressive regulatory intervention since the 2018 Farm Bill legalized hemp nationwide. The legislation targets delta-8 THC, THCA, and other psychoactive compounds sold in gas stations, smoke shops, and online retailers across the state. Lawmakers cited public safety concerns, lack of age verification, and the proliferation of unregulated products as justification for the crackdown. The bill would ban most intoxicating hemp products, impose strict testing requirements, and create a licensed retail framework similar to medical cannabis programs in other states. Industry stakeholders estimate the move affects $400 million in annual hemp sales and threatens thousands of jobs in North Carolina's agricultural and retail sectors. The legislation now heads to the House, where passage would position North Carolina as one of the most restrictive hemp states in the nation despite having no legal adult-use cannabis program.

Why This Matters

North Carolina's hemp crackdown affects 2,800 retail locations, 450 hemp farmers, and an estimated 12,000 workers across the supply chain. The state's hemp industry generated approximately $400 million in retail sales during 2025, according to North Carolina Department of Agriculture estimates. Unlike states with legal recreational cannabis markets, North Carolina consumers have relied on hemp-derived products as the only legal access point for psychoactive cannabinoids. The regulatory shift impacts multiple stakeholder groups. Hemp farmers who invested in THCA flower cultivation face potential crop destruction and loss of contracts with processors. Retailers who built business models around delta-8 vapes, THCA pre-rolls, and hemp-derived edibles confront inventory obsolescence and revenue collapse. Consumers who use these products for pain management, anxiety relief, or recreational purposes lose legal access absent a medical cannabis card, which North Carolina does not currently issue. The legislation also carries broader implications for federalism and cannabis policy. North Carolina's approach tests the boundaries of state authority under the 2018 Farm Bill, which legalized hemp containing less than 0.3% delta-9 THC by dry weight. By restricting hemp derivatives that meet federal THC thresholds, North Carolina joins a growing coalition of states asserting regulatory control over intoxicating cannabinoids regardless of their botanical source. Financial stakeholders include multi-state operators who entered North Carolina's hemp market anticipating regulatory stability, landlords who lease to hemp retailers, and local governments that collect sales tax revenue from hemp transactions. The North Carolina Department of Revenue reported $28 million in sales tax collections from hemp retailers in fiscal year 2025.

Background and History

North Carolina's hemp industry emerged from the 2018 Farm Bill, which removed hemp from Schedule I of the Controlled Substances Act and delegated regulatory authority to states.

2018: Federal Legalization and State Adoption

The Agriculture Improvement Act of 2018, signed December 20, 2018, defined hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. The legislation, championed by Senate Majority Leader Mitch McConnell, explicitly legalized hemp cultivation, processing, and sale under state-approved programs. North Carolina's General Assembly passed Senate Bill 315 in June 2019, establishing the North Carolina Industrial Hemp Pilot Program under the state Department of Agriculture and Consumer Services. The initial program focused on fiber and seed production. Farmers registered 1,200 acres for hemp cultivation in 2019, primarily for CBD extraction. The market remained small, with most production destined for wholesale CBD isolate sales to out-of-state processors.

2020-2021: Delta-8 THC Emergence

The delta-8 THC market exploded in 2020 following chemical innovations that allowed processors to convert CBD isolate into delta-8 through isomerization. Delta-8, a psychoactive cannabinoid occurring naturally in trace amounts, produces intoxicating effects similar to delta-9 THC but remains legal under the Farm Bill's definition when derived from compliant hemp. North Carolina retailers began stocking delta-8 vapes, gummies, and tinctures in late 2020. The North Carolina Department of Agriculture issued guidance in March 2021 stating that hemp-derived delta-8 products complied with state law provided the delta-9 THC content remained below 0.3%. This interpretation opened the floodgates for retail expansion. By December 2021, an estimated 800 North Carolina retailers sold delta-8 products, including convenience stores, vape shops, and dedicated hemp boutiques. The North Carolina Retail Merchants Association reported member complaints about lack of age restrictions and product testing standards.

2022: THCA Flower Enters the Market

Hemp farmers discovered a more lucrative product in 2022: THCA flower. Tetrahydrocannabinolic acid (THCA) is the non-intoxicating precursor to delta-9 THC found in raw cannabis. When heated through smoking or vaping, THCA converts to delta-9 THC through decarboxylation. Hemp cultivators bred high-THCA strains that tested below 0.3% delta-9 THC in their raw state but produced potent psychoactive effects when consumed. North Carolina's climate proved ideal for outdoor THCA cultivation. Farmers in Rutherford County, Yadkin County, and Wilkes County planted high-THCA genetics including strains marketed as Wedding Cake, Gelato, and OG Kush. The flower sold for $800-$1,200 per pound wholesale, compared to $200-$400 for CBD biomass. The North Carolina Department of Agriculture conducted compliance testing based on pre-harvest delta-9 THC levels, not post-decarboxylation totals. This testing methodology, consistent with USDA hemp regulations, allowed THCA flower to pass inspection despite its intoxicating potential. Retail sales of THCA flower surged in 2023. Smoke shops and hemp dispensaries sold THCA pre-rolls and eighth-ounce jars alongside delta-8 products. The market attracted national brands including Hometown Hero, Binoid, and Exhale Wellness, which shipped THCA products to North Carolina consumers via USPS and private carriers.

2023-2024: Law Enforcement and Legislative Pressure

North Carolina sheriffs and district attorneys began voicing concerns in 2023. The North Carolina Sheriffs' Association passed a resolution in August 2023 calling for state regulation of intoxicating hemp products, citing difficulties distinguishing legal hemp from illegal marijuana during traffic stops and investigations. The North Carolina Pediatric Society issued a position statement in November 2023 warning about delta-8 and THCA access among minors. The group cited North Carolina Poison Control data showing 47 calls related to pediatric hemp product ingestion in 2023, up from 12 in 2021. Representative John Bradford, a Republican from Mecklenburg County, introduced House Bill 563 in March 2024 proposing to ban delta-8 and other synthetic cannabinoids. The bill stalled in committee after hemp industry advocates mobilized opposition, arguing the measure would destroy a legal agricultural sector without addressing public safety concerns through regulation. The North Carolina Hemp Association formed in May 2024 to represent farmers, processors, and retailers. The trade group advocated for age restrictions, testing requirements, and labeling standards as alternatives to prohibition.

2025: Market Maturation and Regulatory Gaps

North Carolina's hemp market reached an estimated $400 million in retail sales during 2025. The North Carolina Department of Agriculture licensed 450 hemp farmers cultivating 8,200 acres, with approximately 60% dedicated to THCA flower production. An additional 2,300 retail locations sold hemp-derived products, ranging from standalone dispensaries to gas station counters. The regulatory vacuum became increasingly apparent. No state agency conducted retail inspections for age compliance. No mandatory testing existed for pesticides, heavy metals, or potency accuracy. Product labels often listed THC content as "less than 0.3%" without distinguishing between delta-9, delta-8, THCA, or total THC. The North Carolina Department of Health and Human Services reported 156 emergency department visits in 2025 involving hemp product consumption, including cases of cannabinoid hyperemesis syndrome and acute psychosis. While the numbers remained small compared to alcohol or prescription drug incidents, the upward trend alarmed public health officials.

2026: Legislative Action

Senate Bill 711, titled the "North Carolina Hemp Safety Act," was introduced in April 2026 by Senator Joyce Krawiec, a Republican from Forsyth County. The bill proposed banning all intoxicating hemp products except those sold through a new state-licensed retail system with mandatory testing, child-resistant packaging, and 21+ age verification. The Senate Agriculture Committee held four hearings between May and June 2026. Hemp farmers testified that the bill would force them to destroy crops and breach existing contracts. Retailers argued the legislation favored large operators who could afford licensing fees while eliminating small businesses. Medical professionals and law enforcement representatives supported the restrictions, emphasizing public safety and youth access prevention. The full Senate voted 28-20 on July 3, 2026, to advance the bill. Senator Krawiec stated during floor debate that "doing nothing was not an option" given the proliferation of unregulated intoxicating products. The legislation now moves to the House, where Agriculture Committee Chairman Jimmy Dixon has indicated openness to amendments addressing farmer transition assistance and retail licensing timelines.

Key Players

Senator Joyce Krawiec

Senator Joyce Krawiec, a Republican representing Forsyth County since 2013, serves as the primary sponsor of Senate Bill 711. Krawiec chairs the Senate Health Care Committee and has previously sponsored legislation restricting flavored tobacco products and vaping devices. She framed the hemp crackdown as a public health measure, emphasizing the need to prevent youth access and ensure product safety through testing requirements. Krawiec's district includes Winston-Salem, where several high-profile cases of delta-8 sales to minors generated local media coverage in 2025.

North Carolina Hemp Association

The North Carolina Hemp Association, formed in May 2024, represents approximately 280 farmers, processors, and retailers. Executive Director Brandon Wyatt, a former tobacco farmer who transitioned to hemp cultivation, has lobbied against prohibition in favor of regulatory frameworks that preserve market access. The association proposed alternative legislation including mandatory COA (certificate of analysis) posting, 21+ age restrictions, and a state hemp retailer registry. The group argues that North Carolina's hemp industry provides economic opportunities in rural counties where tobacco farming declined.

North Carolina Sheriffs' Association

The North Carolina Sheriffs' Association, representing all 100 county sheriffs, endorsed Senate Bill 711 in May 2026. The organization cited officer safety concerns and the difficulty of field-testing hemp versus marijuana. Sheriff Donnie Harrison of Wake County testified that deputies cannot visually or olfactorily distinguish THCA flower from illegal cannabis, complicating probable cause determinations during traffic stops. The association supports the bill's provision allowing law enforcement to use total THC testing (including THCA) rather than delta-9 THC alone.

North Carolina Department of Agriculture and Consumer Services

The North Carolina Department of Agriculture and Consumer Services administers the state's hemp program under Commissioner Steve Troxler, who has held the position since 2005. The department opposed earlier prohibition proposals, arguing that hemp represents a viable alternative crop for struggling farmers. However, Commissioner Troxler issued a statement in June 2026 acknowledging that "the current regulatory framework does not adequately address intoxicating hemp products" and expressing willingness to implement testing and retail oversight if the General Assembly provides funding and statutory authority.

North Carolina Pediatric Society

The North Carolina Pediatric Society, representing 1,200 pediatricians statewide, has advocated for restrictions on intoxicating hemp products since 2023. Dr. Kathleen Rounds, a pediatric emergency medicine physician at UNC Children's Hospital, testified before the Senate Agriculture Committee about cases of accidental ingestion by children who mistook delta-8 gummies for candy. The organization supports Senate Bill 711's packaging requirements and retail restrictions but has called for additional funding for public education campaigns about cannabis product risks.

Legal and Regulatory Framework

North Carolina's hemp crackdown operates within the complex interplay of federal hemp law, state agriculture statutes, and controlled substances regulations. The 2018 Farm Bill, codified at 7 U.S.C. § 1639o et seq., removed hemp from the definition of marijuana in the Controlled Substances Act (21 U.S.C. § 802). The federal statute defines hemp as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition created a legal distinction based solely on delta-9 THC concentration, not total THC or intoxicating potential. The USDA's final rule on hemp production, published in January 2021, requires testing for total THC (delta-9 THC plus THCA multiplied by 0.877) for compliance purposes, but only for pre-harvest agricultural testing. Post-harvest hemp products fall under FDA jurisdiction for safety and labeling, but the FDA has not established a comprehensive regulatory framework for hemp-derived cannabinoids. North Carolina General Statute § 106-568.51 established the state's hemp program in 2019, incorporating the federal definition of hemp. The statute does not explicitly address delta-8 THC, THCA, or other intoxicating cannabinoids derived from compliant hemp. This statutory silence created the regulatory gap that Senate Bill 711 seeks to close. Senate Bill 711 proposes to amend § 106-568.51 by adding definitions for "intoxicating hemp product" (any hemp-derived product containing more than 0.5 mg of total THC per serving or designed for inhalation) and "total THC" (the sum of delta-9 THC, THCA multiplied by 0.877, delta-8 THC, and delta-10 THC). The bill would prohibit the sale of intoxicating hemp products except through licensed retailers who meet testing, packaging, and age verification requirements. The legislation raises preemption questions under the Farm Bill. Hemp industry attorneys argue that states cannot ban products that comply with federal hemp definitions, citing the Farm Bill's explicit legalization of "all derivatives, extracts, cannabinoids" from compliant hemp. State lawmakers counter that the Farm Bill preserved state authority to regulate hemp more restrictively, pointing to 7 U.S.C. § 1639o(a)(3)(A), which allows states to prohibit hemp production entirely. No federal court has definitively resolved this tension. The U.S. Court of Appeals for the Ninth Circuit declined to address the issue in Foss v. City of Oakland (2023), finding that the plaintiff lacked standing. Several state courts have upheld delta-8 bans, including the South Dakota Supreme Court in Brakhage v. Noem (2024), which held that states retain police power to regulate intoxicating substances regardless of federal hemp law. North Carolina's approach also implicates the Commerce Clause. By restricting online sales and out-of-state hemp products, Senate Bill 711 could face challenges under the dormant Commerce Clause doctrine, which prohibits states from discriminating against interstate commerce. However, courts generally defer to state regulation of intoxicating substances under the Twenty-first Amendment framework, which grants states broad authority over alcohol despite Commerce Clause concerns.

State-by-State Landscape

North Carolina's hemp crackdown reflects a national trend of states reasserting regulatory control over intoxicating cannabinoids following the 2018 Farm Bill.

States with Comprehensive Hemp Restrictions

State	Effective Date	Key Restrictions	Penalties
Colorado	July 1, 2023	Ban on delta-8, delta-10, THCO; THCA flower limited to licensed cannabis retailers	Class 2 misdemeanor; $1,000 fine
Oregon	June 30, 2023	Artificially derived cannabinoids prohibited; THCA flower requires OLCC license	Class A violation; $2,000 fine
Montana	October 1, 2023	Total THC limit of 0.3%; effectively bans THCA flower and delta-8	Misdemeanor; 6 months jail
Rhode Island	January 1, 2024	All intoxicating hemp products must be sold through licensed cannabis retailers	Civil penalty; $10,000 fine

California

California enacted Assembly Bill 45 in October 2023, requiring all hemp products containing detectable THC to be sold exclusively through licensed cannabis retailers. The law took effect January 1, 2024, and imposed a total THC limit of 0.3% for hemp products sold outside the licensed system. California's Department of Cannabis Control issued emergency regulations in March 2024 establishing testing requirements for hemp-derived cannabinoids equivalent to those for cannabis products, including pesticide screening, heavy metals analysis, and potency verification. Unlicensed retailers faced enforcement actions beginning July 2024, with the Department of Tax and Fee Administration conducting compliance sweeps that resulted in 340 cease-and-desist orders statewide.

New York

New York's Office of Cannabis Management issued regulations in September 2023 prohibiting the sale of any cannabinoid product containing more than 0.3% total THC outside the licensed adult-use cannabis program. The regulations defined total THC to include delta-9 THC, THCA, delta-8 THC, and other intoxicating isomers. The state provided a six-month transition period ending March 31, 2024, during which unlicensed hemp retailers could sell existing inventory. New York's approach emphasized enforcement through the Department of Taxation and Finance, which audited hemp retailers for sales tax compliance and issued violations for products exceeding THC limits.

Minnesota

Minnesota took a regulatory rather than prohibitory approach with the passage of House File 4065 in May 2023. The legislation created a tiered system for hemp-derived edibles, limiting delta-9 THC to 5 mg per serving and 50 mg per package for products sold outside licensed cannabis dispensaries. The law permitted delta-8 and other hemp-derived cannabinoids but required registration with the Minnesota Board of Pharmacy, third-party lab testing, and child-resistant packaging. Minnesota's model preserved hemp retail access while imposing safety standards, generating approximately $12 million in registration fees and testing compliance costs during the first year of implementation.

States Maintaining Permissive Hemp Policies

Several states have declined to restrict intoxicating hemp products despite the national trend. Texas, Florida, Georgia, and Tennessee continue to allow delta-8, THCA flower, and other hemp-derived cannabinoids under the federal definition. These states have not established comprehensive testing or retail licensing requirements, relying instead on federal hemp compliance and general consumer protection laws. The permissive approach has made these states hubs for hemp product manufacturing and distribution, with Florida's hemp industry generating an estimated $1.2 billion in annual sales as of 2025.

Market and Business Implications

North Carolina's hemp restrictions threaten to eliminate $400 million in annual retail sales and force market consolidation favoring multi-state operators with capital to navigate licensing requirements. The immediate impact falls on small retailers who built businesses around hemp-derived products. A typical smoke shop in Raleigh or Charlotte derives 60-70% of revenue from delta-8 vapes, THCA flower, and hemp edibles, according to North Carolina Hemp Association surveys. If Senate Bill 711 passes without amendments, these retailers face three options: obtain expensive state licenses, pivot to non-intoxicating CBD products, or close. The licensing framework proposed in Senate Bill 711 requires a $10,000 annual fee, $50,000 surety bond, and compliance with testing standards estimated to cost $200-$400 per product SKU. These barriers favor established cannabis operators and well-capitalized entrants while excluding mom-and-pop shops that currently dominate North Carolina's hemp retail landscape. Hemp farmers confront even more severe disruption. Growers who planted THCA genetics in spring 2026 anticipating fall harvest face potential crop destruction if the bill becomes law before harvest. A 10-acre THCA operation represents approximately $120,000 in input costs (seeds, irrigation, labor, testing) with expected gross revenue of $400,000-$600,000. The legislation includes no compensation mechanism for crop loss or contract breach damages. Wholesale pricing has already declined in anticipation of regulatory changes. THCA flower that sold for $1,000 per pound in January 2026 dropped to $600 per pound by June 2026 as processors reduced inventory purchases. Delta-8 distillate prices fell from $1,200 per kilogram to $800 per kilogram over the same period. Multi-state operators view North Carolina's crackdown as a market consolidation opportunity. Curaleaf, Trulieve, and Green Thumb Industries have indicated interest in applying for North Carolina hemp retail licenses if the bill passes, leveraging their existing compliance infrastructure and testing relationships from operations in other states. These companies can absorb the licensing costs and testing requirements that eliminate smaller competitors. The legislation also impacts ancillary businesses. Commercial landlords who lease to hemp retailers face tenant defaults and vacancy. Payment processors who serve the hemp industry confront reduced transaction volume. Marketing and branding agencies that specialize in hemp products lose clients. Tax revenue implications remain uncertain. North Carolina collected approximately $28 million in sales tax from hemp retailers in fiscal year 2025. Senate Bill 711 would likely reduce this revenue in the short term as unlicensed retailers exit the market, but proponents argue that a licensed system with higher-priced products could eventually generate comparable or greater tax collections. The bill does not establish a separate excise tax on hemp products, unlike cannabis taxation schemes in states such as California (15% excise tax) or Illinois (cannabis products tax ranging from 10-25% based on THC content). This represents a missed revenue opportunity that some legislators have noted during committee hearings. Capital markets have responded negatively to hemp regulatory uncertainty. Hemp-focused companies including Hometown Hero and Binoid saw private valuations decline 30-40% during 2025 as state crackdowns spread. Venture capital investment in hemp startups fell from $240 million in 2023 to $85 million in 2025, according to Viridian Capital Advisors data.

What Experts Say

Legal scholars, industry analysts, and public health experts offer divergent perspectives on North Carolina's regulatory approach, with debate centering on federalism, public safety, and economic impact. Professor Robert Mikos of Vanderbilt Law School, a leading expert on cannabis federalism, has argued that states retain authority to restrict intoxicating hemp products despite the 2018 Farm Bill. According to Mikos, the Farm Bill legalized hemp cultivation and interstate commerce but did not preempt state police power to regulate intoxicating substances. He noted in a 2024 law review article that the Farm Bill's savings clause explicitly preserves state authority to prohibit hemp production, and courts have historically granted states broad discretion in regulating psychoactive substances. Conversely, attorney Rod Kight, who specializes in hemp and cannabis law, has contended that state bans on compliant hemp products violate congressional intent behind the 2018 Farm Bill. Kight pointed to the statute's explicit legalization of "all derivatives, extracts, cannabinoids" from hemp and argued that states cannot selectively prohibit specific cannabinoids that meet federal THC thresholds. He has represented hemp companies in litigation challenging state restrictions in multiple jurisdictions. Dr. Beatriz Carlini, a research scientist at the University of Washington's Addictions, Drug & Alcohol Institute, has studied delta-8 and THCA product safety. Her research, published in the Journal of Cannabis Research in 2024, found significant variability in product potency and contamination rates among unregulated hemp products. Testing of 60 delta-8 products purchased in Washington state revealed that 42% exceeded labeled THC content by more than 20%, and 18% contained detectable pesticides above safety thresholds. Carlini has advocated for mandatory testing and labeling requirements rather than outright prohibition. Economic analyst Beau Whitney of Whitney Economics, a firm specializing in cannabis market research, has estimated that state hemp crackdowns have eliminated approximately $2.8 billion in national hemp-derived cannabinoid sales between 2023 and 2025. Whitney's analysis suggests that restrictive states have not seen corresponding increases in licensed cannabis sales, indicating that consumers either reduce consumption or turn to illicit markets rather than paying premium prices in licensed systems. The North Carolina Medical Society has not taken an official position on Senate Bill 711, but individual physicians have expressed support for age restrictions and testing requirements. Dr. Michael Cary, an addiction medicine specialist at Duke University Hospital, has stated that emergency department presentations involving hemp product consumption have increased but remain manageable compared to alcohol or opioid cases. He has emphasized the need for product standardization and consumer education rather than prohibition. Agricultural economists at North Carolina State University have analyzed the bill's impact on farming communities. Dr. Blake Brown, a professor of agricultural and resource economics, has noted that hemp provided a viable alternative for tobacco farmers facing declining demand, generating approximately $65 million in farm gate revenue in 2025. Brown's research suggests that eliminating THCA cultivation would reduce this figure by 60-70%, with limited alternative crops offering comparable profitability in North Carolina's climate.

What's Next

Senate Bill 711 now advances to the North Carolina House of Representatives, where passage would require approval by the Agriculture Committee, floor vote, and signature by Governor Roy Cooper. The House Agriculture Committee, chaired by Representative Jimmy Dixon, has scheduled initial hearings for late July 2026. Dixon has indicated openness to amendments addressing industry concerns, including extended transition periods for farmers to harvest existing crops and tiered licensing fees based on business size. The committee includes members from rural districts where hemp farming has provided economic benefits, creating potential resistance to the Senate's prohibition-focused approach. Key decision points include:

• August 15, 2026: House Agriculture Committee vote deadline before the summer recess
• September 2026: Full House floor vote if the bill clears committee
• October 2026: Potential conference committee to reconcile House amendments with Senate version
• November 2026: Governor's signature or veto deadline
• January 1, 2027: Proposed effective date in current bill language

Governor Roy Cooper, a Democrat serving his final term, has not publicly stated a position on hemp regulation. Cooper has previously supported medical cannabis legalization and signed legislation decriminalizing small amounts of marijuana possession in 2024. His administration's stance on intoxicating hemp products remains unclear, though the Governor's office has indicated he will review the final legislation if it reaches his desk. Industry groups are mobilizing opposition and proposing compromise frameworks. The North Carolina Hemp Association has drafted alternative language that would preserve THCA flower sales through licensed retailers while banning synthetic cannabinoids like delta-8 and delta-10. This approach mirrors Minnesota's regulatory model and could attract support from legislators seeking middle-ground solutions. Retailers are accelerating inventory liquidation in anticipation of potential restrictions. Smoke shops and hemp dispensaries across North Carolina have advertised clearance sales on delta-8 and THCA products, with some offering 40-50% discounts to move stock before potential prohibition. This fire sale dynamic has further depressed wholesale prices and created cash flow challenges for processors holding large inventories. Several scenarios could emerge from the legislative process: Scenario 1: Senate Bill Passes Largely Intact — The House approves the Senate version with minor amendments, Governor Cooper signs, and comprehensive hemp restrictions take effect January 1, 2027. This outcome would eliminate most intoxicating hemp sales outside a licensed system, forcing market consolidation and farmer crop transitions. Scenario 2: Compromise Legislation — The House substantially amends the bill to preserve THCA flower access while restricting synthetic cannabinoids, establishing testing requirements, and creating a streamlined licensing process with lower fees. This middle path could maintain some hemp market activity while addressing public safety concerns. Scenario 3: Bill Stalls in House — The Agriculture Committee declines to advance the legislation due to rural district opposition, leaving the current regulatory framework in place. This outcome would maintain the status quo but could prompt renewed legislative efforts in 2027. Scenario 4: Gubernatorial Veto — The bill passes both chambers but Governor Cooper vetoes, citing economic impact on farmers and lack of evidence supporting prohibition over regulation. The General Assembly could attempt a veto override requiring three-fifths majority. Legal challenges appear likely regardless of the legislative outcome. Hemp industry attorneys have indicated plans to file suit challenging any prohibition on federalism and Commerce Clause grounds. Potential plaintiffs include the North Carolina Hemp Association, individual farmers facing crop destruction, and retailers forced to close. Litigation could delay implementation while courts resolve constitutional questions. The federal regulatory landscape may also shift. The FDA has indicated plans to issue guidance on hemp-derived cannabinoids in late 2026, potentially establishing national standards for delta-8, THCA, and other compounds. Federal action could preempt state restrictions or provide a framework that North Carolina adopts in lieu of state-specific rules.

Further Reading

• 2018 Farm Bill (Agriculture Improvement Act of 2018), Public Law 115-334, available at https://www.congress.gov/bill/115th-congress/house-bill/2
• USDA Final Rule on Domestic Hemp Production, 7 CFR Part 990, published January 19, 2021, available at https://www.federalregister.gov/documents/2021/01/19/2021-00967/establishment-of-a-domestic-hemp-production-program
• North Carolina General Statute § 106-568.51 et seq., Industrial Hemp Pilot Program, available at https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/BySection/Chapter_106/GS_106-568.51.html
• North Carolina Senate Bill 711 (2026), Hemp Safety Act, full text available at https://www.ncleg.gov/BillLookUp/2026/S711
• North Carolina Department of Agriculture and Consumer Services, Industrial Hemp Program, https://www.ncagr.gov/hemp/
• Mikos, Robert A., "The Limits of Supremacy: Medical Marijuana and the States' Overlooked Power to Legalize Federal Crime," Vanderbilt Law Review, Vol. 62, 2009
• Carlini, Beatriz H., et al., "Identification of Adulteration in Commercial Cannabidiol Products," Journal of Cannabis Research, Vol. 6, 2024
• North Carolina Sheriffs' Association, Resolution on Intoxicating Hemp Products, August 2023, available at https://ncsheriffs.org/
• Whitney Economics, "The State of the Hemp-Derived Cannabinoid Market 2025," industry report, March 2025
• DEA Interim Final Rule on Tetrahydrocannabinols, 86 FR 51639, August 21, 2020, available at https://www.federalregister.gov/documents/2020/08/21/2020-18719/implementation-of-the-agriculture-improvement-act-of-2018